Biocodex is a French pharmaceutical company founded in 1953 to develop and market the world’s first probiotic yeast strain, Saccharomyces boulardii CNCM I-745®. Today, Biocodex focuses its business on three main areas: Microbiota care; Women’s health; Orphan diseases. With more than 1,700 employees, Biocodex generated net revenues of above €500 million in 2023, including 1/3 in France and 2/3 internationally. The group is present in more than 100 countries through wholly owned subsidiaries in 16 countries and a network of distributors worldwide.
To report quality complaint(s) or adverse event(s) related to Biocodex products please visit https://www.biocoreport.com/en/
Company Details
- Employees
- 1.59K
- Founded
- -
- Address
- 22, Rue Des Aqueducs, Gentilly,île-De-France 94250,france
- Phone
- +33 (0)1 41 24 30 00
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- biocodex.fr
- Keywords
- Gastroenterology, Neurology/Psychiatry, Pain management, Pédiatry, Rheumatology, Otolaryngology, women's health.
- HQ
- Gentilly, Île-de-France
Biocodex Questions
Biocodex's helpline number is +33 (0)1 41 24 30 00
Biocodex's website is biocodex.fr
Biocodex's LinkedIn profile is https://www.linkedin.com/company/biocodex
Biocodex has
1.59K employees.
View email and phone details for 1.59K
employees at Biocodex.
Biocodex's industry is
Pharmaceutical Manufacturing
Biocodex's top competitors are
Astrazeneca,
Viatris,
Pfizer,
Roche,
Novartis,
Sanofi,
Pierre Fabre Laboratories,
Gsk,
Bayer,
Biogaran.
Biocodex's categories are Pharmaceutical Manufacturing
Biocodex's founding year is 1953
